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1. INTRODWCTION 
Protein kinase C (PKC) is known co play a critical 
role in the process of T-cell activation [l-3]. Specific 
antigen, monoclonsrl antibodies or mitogenic &tins all 
act via the TVCD3 receptor camplex [4] co stimulate 
phospholipase C to praduce diacylglycerol which ac- 
tivates PKC [5,6], There is also an increase in inositol 
triphosphate, leading to elevated levels of free in- 
tracellular Ca’+, which act in synergy with 
diacylglycerol to translocate PKC From the cytosot to 
the plasma membrane, where it appears in the active 
state [7j. 
There are at least seven isoforms of PKC; they exhibit 
significant homologies, but also distinct differences, 
both in their biochemical properties and in their tissue 
distribution [$I. T-cells have so far been shown to con- 
tain at least two of these forms, CT- and P-PKC @-PKC 
consisting of two separate forms, PI and @II) 19, IO]. 
Both the LY- apd the&isoforms are translocated follow- 
ing stimulation with phorbol esters or diacylglycerols 
that directly bind to, and activate PKC [l l]. The roles 
of the different PKCs are still poorly understood, as is 
the reason why most cells possess more than one type of 
PKC. In T-cells, it was recently shown that the propor- 
tions of GJ- and ,&PKC vary between different cell lines, 
suggesting the possibility of isoenzyme-specific effects 
[12]. It is also possible that the isoforms of PKC are 
selectively activated in response to different stimuli. 
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This was recently demonstrated in Wctn cells, where 
intccfcron- (which increases diacyl&cerol production 
without afr,ciing intracellular Ca2+ levels), but not 
epidermal growth Factor (which increases both), setec- 
cively translocatcs ,&PKC but not cv-PKC [13]. 
The present study was carried out in order to 
elucidate which isoforms of PKC are translocated 
following stimulation with the mitogenic leccin, Con A, 
which acts via the Ti/CD3 receptor complex [14]. 
2, EXPERIMENTAL 
2, I r Cell.s 
The human leukemic T-cell line, Jurknt, was maintained in 
RPMI-1640 supplemented with 7.5% foctal calf serum, L-glutamine 
and pcniclilin/streptomycin. 
2.2, Chemicals 
PMA, Con A, PHA, biotinylatcd goat anti-rabbit antibody, 
alknline pllosphatasc-conjugated avidin, 5-bromo.4.chloro-3.indoyl 
phosphate (BCIP) and Nitro blue tctrazolium (NBT) were from 
Sigma, St. Louis, USA. The monoclonal anti-CD3 antibody, OKT3, 
was purified from hybridoma supcrnatant. The MC5 mouse 
monoclonal antibody to (Y/&PKC was from Amersham (Buck- 
inghamshire, UK). Rabbit antisera to the PKC rx- and&isoforms were 
kindly donated by Professor Yasutomi Nishizuka (Kobc, Japan). 
The cy-serum is against the synthetic pcptide QFVHPILQSAV and 
the p..scrum is against the synthetic peptide 
FARKGALRQKNVHEVKNHKF. 
2.3. Sepuralion of cylosolic and tnembrane-bound PKC 
Jurkat cells were stimulated with phorbol ester or Con A at a cell 
density of IO x lO”/ml at 37°C. Incubations were stopped by rapid 
centrifugrtion followed by the addition of ice-cold phosphatc- 
buffered saline (PUS). Cytosolic and membrane-bound PKC were 
separated essentially as described by Pelech et al. with minor 
modifications [15]. Briefly, cells were pcrmcabilized for 5 min at 4°C 
under constant whirl-mixing with 0.5 ml digitonin buffer (20 mM 
Tris, pH 7.5,2 nrM EDT& 0.5 mM EGTA, 1 mM dithiothreitol with 
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wan blocked by Insubetian of mfrnbrrncr En PBS contuifiing 3% 
bovine .%xum nlbumin and normal mouxe ~erunl i\t 1 : 100 Dilution Fi& I I Tronaloa~ian eT BtK in Jurkrl c~lla. fhc TiJClX rcczptor 
(nat added IO ~hc MCS4n~ibody). hltcr wnxhing 0r Ilrc filrera, nn- c‘amplcx was duwn~regulnlcd an Jurkm ccllx by ovcrrrighl inrobsGon 
Gbarlicx were Wed al I : 300 dilution in PRS/3~0 buvinc ~crum wilh the onWX3 rnribody, OKT3, c%r3* (A) nnd CR3” (B) cells 
nlbumin. Specific binding WRI Jctct~I by udng bloilnddin~ WFC then nGmulrexi wklr PMA (I80 nM, 10 min), Con A (28~&ml, 
alkalino phospharnsc wilh S.brome.4.chloro.3.inrlorl phesphnlc 5 min) Rntl PHA (2O&flil, f mia) whcreahcr Ihe eyrorolie und 
(BCIP) and Nhro blur tc~rrnc~lium (MT) US xub~ra~e. The blor~ WPYC mcmbranr rrueGona were xrprr~~ed and WC rrunrlocorion snalyxctl 
dcnsiIomcrrirnlly rcnnnrtl urinp a Microcompurcr lmnging Device us dcricribcd in rcction 2. Only ~lrc nrcmbrrnc lraetianJ are r,tjown, 
(Imaging Rcscareh, Toronto, Carala). The! nrrow ahowa Ihe peaidon of PKC, Molcrular ma$% markers nrc 
shown in kBa, 
3. RESULTS AND DISCUSSION 
Using the MC5 antibody to both the cy- and .&forms tion of unstimulated cells whereas no&PKC was found 
of PKC, we first analyzed the effect of the phorbol ester (Fig. 2A and C), We could also confirm that Jurkat 
PMA on PKC translocation. In Jurkat cells, PMA ceils contain significantly more cy- than B-PKC [IO]. 
caused a strong and sustained translocation of PKC PMA caused a strong translocarion of both isoforms. 
(Fig. IB), This is in agreement with previous findings, There was, however, a. significant difference in the 
both in T-cells and in other systems. Stimulation of amount of PKC remaining in the cytosolic fraction 
Jurkat cells with the mitogenic lectins Con A or PHA, after PMA stimulation. Whereas &PKC translocation 
both of which act via phospholipase C (PLC), also was almost otal, a substantial amount of the o-form re- 
caused a readily detectable translocation of PKC mained in the cytosol (approximately 30% as measured 
(Fig. 1B). Downregulation of the CD3 receptor by in- by densitometric scanning). This may be explained by a 
c’ubation with OKT3 antibodies prevented the Con A difference in the requirement of additional factors, e.g, 
and PHA stimulated translocation of PKC (Fig. 1A). Ca2* between the isoforms. Indeed, it has been shown 
When this antibody was used, no PKC was found that ;he a-form is highly sensitive to intracellular Ca2* 
translocated in unstimulated cells if the cells were lysed whereas the &form is not [g]. When Jurkat cells were 
under calcium-chelating conditions. If the unstimulated stimulated with Con A, both the a- and the ,8-isoforms 
cells were first perrneabilized in digitonin without of PKC were translocated as shown in Fig. 2A and C, 
c&ium-chelators, a substantial amount of PKC was No decrease in the cytosolic fraction was detected, 
found in the membranes (not shown). The relative ef- which probably reflects the fact that only a relatively 
feet of Con A or PHA stimulation on the PKC distribu- small proportion of the PKC is translocated following 
tion was the same under both lysis conditions. This sug- activation of these cells, By using depsitometric scann- 
gests that both Con A and PHA are able to produce ing we could estimate the amount of translocated PKC 
translocation of PKC that exceeds the basal to 25% for the a-form and approximately 10% for the 
Ca*+-dependent translocation. Since calcium- P-form. The translocation was transient for both 
ionophore A23187 alone does not increase the en- forms, with changes in the distribution of the P-form 
zymatic activity of PKC in the membrane fraction of occurring somewhat more rapidly. Thus, the a-form 
Jurkat cells, as measured by histone phosphorylation peaked at 5 min and had not subsided to basal levels 
[IS]; the basal translocation does not necessarily imply after 30 min, whereas the &form peaked at 1 min and 
activation. was down to basal evels within 30 min (Fig. 213 and D). 
We next analyzed the effects of PMA and Con A These differences may be related to the differemxs in 
stimulation on the translocation of the tr- and &forms diacylglycerol and Ca2” requirement. 
of PKC (more specifically, the LY- and ,&I-forms, since Some recent reports have focused on the possible 
Jurkat cells do not contain the ,&I-form) [lo]. A small significance of the cellular specificity in the setup of 
amount of a-P&X could be seen in the membrane frac- PKC isoforms. The isoforms have different 
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Fig. 2. frnnslocation of CY- and &PKC in Jurkat cells. Jwrkat cells were stimulated with PMA (100 nM, 10 min) and Con A (20 &t/ml). After 
separation of cytosolic and membrane fractions, translocation of cy- (A) and ,&PKC (C) was detected as described in section 2, The arrow shows 
the position of PKC. Molecular weight markers are shown in kDa. Dcnsitomctric scanning of three independent experiments was done on (Y- (g) 
and ,f~‘-PKC (D) trnnslocation and the result expressed in arbitrary units A- SE, The irttensity of the PKC band was corrected for variations in 
background staining. 
biochemical characteristics [8], and differential activa- in kinetics between the LT- and&forms of PKC in Jurkat 
tion may occur following stimulation with agonists that cells may be that they are translocated to separate 
activate PKC through different mechanisms, e.g. subcellular membranes. Further studies will be required 
phospholipase C and phospholipase D. It was recently to analyze the possibility of selective translocation of 
shown that thyreotropin-releasing hormone, which ac- different PKC isoforms in T-cells. 
tivates phospholipase C, may translocate both the ky- 
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